The Terry Fox Research Institute (TFRI) is pleased to announce the appointment of Dr. Tony Reiman as its Atlantic Node Leader, representing the provinces of Newfoundland and Labrador, New Brunswick, Nova Scotia and Prince Edward Island on TFRI’s Executive.
Based in Saint John, New Brunswick, Dr. Reiman is a medical oncologist at the Saint John Regional Hospital, the Canadian Cancer Society Research Chair at the University of New Brunswick, and a professor of medicine at Dalhousie University. He replaces Dr. Michael Johnston of Dalhousie University who held the role for the past decade.
“Dr. Reiman is an exemplary addition to the TFRI Executive and as a representative for our partners and stakeholders in Atlantic Canada. We are extremely grateful that he has taken on this leadership role which will help us to further enhance our partnerships with our research partners and importantly, work together to improve outcomes for patients in this important part of the country as we move ahead with our Marathon of Hope Cancer Centres Network,” says Dr. Victor Ling, TFRI president and scientific director.
“It is meaningful to me to be involved in supporting cancer research in my home and region, here in Atlantic Canada, where Terry started his epic journey. It is an honour to be the newest representative on the TFRI Executive and to help carry on Terry’s work with a remarkable team,” says Dr. Reiman.
“It is important that all parts of Canada have the opportunity to contribute to, and benefit from, participation in world-class cancer research.”
Like many cancer researchers in Canada, Dr. Reiman holds Terry’s legacy in high esteem. “I was an impressionable elementary school student making a journey of my own across Eastern Canada with my family, when Terry Fox made his legendary run across Canada to raise funds for cancer research. He was then, and is now, a hero and an inspiration to me and to so many people across Canada and around the world.”
Dr. Reiman leads TFRI’s pan-Canadian project Multiple Myeloma Molecular Monitoring (M4 study), which is comprised of researchers and clinicians at multiple sites including Vancouver, Calgary, Toronto and Montreal. In addition to treating cancer patients in Saint John, Dr. Reiman’s research focuses on improving the outcomes of cancer treatment, and emphasizes engaging patients as both participants and partners in research. He is also involved in the creation of the Atlantic Cancer Consortium, which will join the Marathon of Hope Cancer Centres Network within the next year.
He and his colleagues study the biology of, and novel therapeutic approaches to multiple myeloma and other cancers, through both laboratory studies and clinical trials. Dr. Reiman has served in several other local, national and international cancer research leadership roles during his career.